Publications by authors named "J Bellmunt"

Claim this Profile
A
A plain language summary of the TROPiCS-04 study: sacituzumab govitecan use after platinum-based chemotherapy and immunotherapy in people with locally advanced or metastatic cancer of the bladder, urethra, or upper urinary tract.
Thomas Powles, Scott T Tagawa, Christof Vulsteke, Marine Gross-Goupil, Se Hoon Park, Joaquim Bellmunt

Future Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Enfortumab Vedotin After Platinum Chemotherapy and Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Real-World Analysis of the ARON-2EV Cohort.
Ondrej Fiala, Francesco Grillone, Kazutoshi Fujita, Enrique Grande, Patrizia Giannatempo, Joaquim Bellmunt

Eur Urol Open Sci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic prognostication of non-muscle invasive bladder cancer using conditional recurrence- and progression-free survival: A SEER-Medicare analysis.
Jenny Chia-Chen Chang, Agustin Perez-Londoño, Sumedh Kaul, Jamil Almohtasib, Aaron Fleishman, Joaquim Bellmunt

Urol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.
Rana R McKay, Sumanta Pal, Wanling Xie, David Aggen, Laurence Albiges, Joaquim Bellmunt

CA Cancer J Clin· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary outcomes and disease burden of high-grade T1 bladder cancer.
Agustin Perez-Londoño, Sumedh Kaul, Aaron Fleishman, Ruslan Korets, Heidi Rayala, Joaquim Bellmunt

Can Urol Assoc J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis